(Q56505206)

English

Lung Transplantation

article

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Lung Transplantation (English)

0 references

lung transplant

1 reference

based on heuristic

inferred from title

author name string

Robert M Kotloff

1

0 references

Gabriel Thabut

2

0 references

language of work or name

0 references

publication date

15 July 2011

0 references

American Journal of Respiratory and Critical Care Medicine

0 references

184

0 references

2

0 references

159-171

0 references

LUNG HOMOTRANSPLANTATION IN MAN

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report--2010.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung transplantation in the United States, 1999-2008.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Systemic sclerosis and bilateral lung transplantation: a single centre experience

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Obesity and underweight are associated with an increased risk of death after lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung transplantation in older patients?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Should lung transplantation be performed for patients on mechanical respiratory support? The US experience

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Increasing lung allocation scores predict worsened survival among lung transplant recipients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

High lung allocation score is associated with increased morbidity and mortality following transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Development of a predictive model for long-term survival after lung transplantation and implications for the lung allocation score

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

A review of lung transplant donor acceptability criteria.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung donor selection and management.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Strategies to optimize the use of currently available lung donors.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Availability of lungs for transplantation: exploring the real potential of the donor pool.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Ex vivo evaluation of nonacceptable donor lungs.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Functional repair of human donor lungs by IL-10 gene therapy.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung transplantation with donation after cardiac death donors: long-term follow-up in a single center

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Should lung transplantation be performed using donation after cardiac death? The United States experience

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Single vs bilateral, sequential lung transplantation for end-stage emphysema: influence of recipient age on survival and secondary end-points

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung transplantation for idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Survival after bilateral versus single-lung transplantation for idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Comparison of wait times and mortality for idiopathic pulmonary fibrosis patients listed for single or bilateral lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Survival effect of lung transplantation among patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Disease-specific survival benefit of lung transplantation in adults: a national cohort study.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Use of lung transplantation survival models to refine patient selection in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung transplantation and survival in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung transplantation and survival in children with cystic fibrosis: solid statistics--flawed interpretation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung transplantation in children with cystic fibrosis: a view from Europe.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Technology and outcomes assessment in lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Quality, quantity, or both? Life after lung transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Primary graft failure following lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Clinical risk factors for primary graft failure following lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

High donor age, low donor oxygenation, and high recipient inotrope requirements predict early graft dysfunction in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Risk factors for primary graft dysfunction after lung transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Construct validity of the definition of primary graft dysfunction after lung transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

The effect of primary graft dysfunction on survival after lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Primary graft dysfunction and long-term pulmonary function after lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Lung transplant airway hypoxia: a diathesis to fibrosis?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Short-term deployment of self-expanding metallic stents facilitates healing of bronchial dehiscence

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Incidence, management and clinical outcomes of patients with airway complications following lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Postlung transplant survival is equivalent regardless of cytomegalovirus match status.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

The role of innate immunity in acute allograft rejection after lung transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Pulmonary capillaritis in lung transplant recipients: treatment and effect on allograft function

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Acute antibody-mediated rejection after lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

The predictive value of bronchiolitis obliterans syndrome stage 0-p.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Prognostic value of bronchiolitis obliterans syndrome stage 0-p in single-lung transplant recipients.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Risk factors for bronchiolitis obliterans: a systematic review of recent publications

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

A Randomized Trial of Inhaled Cyclosporine in Lung-Transplant Recipients

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Development of the new lung allocation system in the United States

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Determinants of the Survival Benefit of Lung Transplantation in Patients with Chronic Obstructive Pulmonary Disease

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Galactomannan in Bronchoalveolar Lavage Fluid

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Regeneration and orthotopic transplantation of a bioartificial lung

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201101-0134CI

21 January 2018

Identifiers

10.1164/RCCM.201101-0134CI

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56505206&oldid=2009255949"